双环醇治疗胃癌化疗所致肝损伤患者肝功能指标的变化

doi:10.3969/j.issn.1672-5069.2018.04.036

Abstract

Tong Xin, Fan Hua. Efficacy of bicyclic alcohol on liver function in gastric cancer patients with chemotherapy-induced liver injury[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 625-626.

[1] 刘本,侯秋月.阿拓莫兰对成人急性髓样白血病化疗患者肝功能损伤的预防作用观察. 实用肝脏病杂志, 2016, 19(6):717-719.
[2] Shang W,Feng Y,Li J,et al.Effect of bicyclol tablets on drug induced liver injuries after kidney transplantation.Open Med,2017,12(5),12:62-69.
[3] Louvet A,Athurin P.Alcoholic liver disease: mechanisms of injury and targeted treatment.Nat Rev Gastroenterol Hepatol,2015,12(4):231-242.
[4] 于乐成,茅益民,陈成伟. 药物性肝损伤诊治指南.中国病毒病杂志,2015,23(5):1752-1769.
[5] Li X,Zhou J,Chen S,et al.Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer.J Int Med Res,2014,42(4):906-14.
[6] 王俊华. 双环醇片防治晚期非小细胞肺癌化疗中肝损伤的临床研究. 河北联合大学学报,2015,17(6):216-218.
[7] 余凌虹, 魏怀玲, 鲍秀琦,等.双环醇对奥沙利铂联合5-氟尿嘧啶方案引起肝损伤保护作用的实验研究.中国药物警戒,2013,10(2):68-70.
[8] Liu GT,Li Y,Wei HL,et al.Mechanism of protective action of bicyclol against CCl-induced liver injury in mice.Liver Int,2005,25(4):872-987.
[9] Moreira AJ,Rodrigues G,Bona S,et al.Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats.Toxicol Rep,2015,2(3):333-340.
[10] Chu NH,Li L,Zhang X,et al.Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease. Int J Tuberc Lung Dis,2015,19(4):475-480.
[11] 成军,徐道振. 双环醇保肝的基础与临床研究进展.中华实验和临床感染病杂志:电子版,2008,2(4):354-358.
[12] Zhao J,Chen H,Li Y.Protective effect of bicyclol on acute alcohol-induced liver injury in mice.Eur J Pharmacol,2008,586(1):322-331.
[13] Alimuddin Z,Andrew G,Virendra S,et al.WHO’s 2013 global report on tuberculosis:successes,threats,and opportunities.Lancet,2013,382(9907):1765-1767.
[14] Duran R,Sharma K,Dreher MR,et al.A novel inherently radiopaque bead for transarterial embolization to treat liver cancer-a pre-clinical study. Theranostics,2016,6(1):28-39.
[15] 蔡素华,邱萍英. 双环醇片治疗抗精神病药物所致肝损伤患者的临床疗效及安全性. 中国药物经济学,2016,11(9):94-96.
[16] 涂赟,万以叶. 双环醇片对肺癌患者药物性肝损伤的防治研究. 医学研究杂志,2012,41(7):156-158.
[17] 李燕. 双环醇对刀豆蛋白A引起肝损伤小鼠肝脏基因表达谱的影响. 药学学报,2008,43(6):596-60.

Efficacy of bicyclic alcohol on liver function in gastric cancer patients with chemotherapy-induced liver injury

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[8]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[9]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[10]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[11]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[12]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[13]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[14]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[15]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.